Mizuta Shuichi

■FacultyDepartment of Hematology and Immunology
■PositionProfessor

Researcher Profile & Settings

Research

    Overview of research:
    Novel therapy using molecular target agents

Association Memberships

  • 1996- American Society of Hematology

Research Activities

Research Areas

  • Medicine,dentistry, and pharmacy / Clinical internal medicine

Published Papers

  • Different impact of BCR-ABL transcripts on allogeneic hematopoitic cell transplantation from different graft sources for Ph + ALL with minimal residual disease, (Satoshi Nishiwaki), Shuichi Mizuta, Kazuteru Ohashi, Takahiro Fukuda, Naoyuki Uchida, Takayoshi Tachibana, Makoto Onizuka, Yukiyasu Ozawa, Yasushi Onishi, Satoshi Takahashi, Tetsuya Eto, Hirohisa Nakamae, Junji Tanaka, Tatsuo Ichinohe, Yoshiko Astuta, Shinichi Kato, for the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation, American Journal of Hematology, 94:E301-E305, Nov. 2019
  • Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia, (Yu Akahoshi), Satoshi Nishiwaki, Shuichi Mizuta, Kazuteru Ohashi, Naoyuki Uchida, Masatsugu Tanaka, Takahiro Fukuda, Yukiyasu Ozawa, Satoshi Takahashi, Makoto Onizuka, Souichi Shiratori, Hirohisa Nakamae, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Shinichi Kako, Cancer Science, 110:3255-3266, Oct. 2019
  • Osteosarcoma Manifesting Systemic Inflammation and Histological Features Mimicking Plasma Cell-type Castleman Disease, Shino Fujimoto, Tomoyuki Sakai, Hiroshi Kawabata, Nozomu Kurose, Sohsuke Yamada, Mariko Doai, Munetaka Matoba, Haruka Iwao-Kawanami, Takafumi Kawanami, Shuichi Mizuta, Toshihiro Fukushima, Hiroki Mizumaki, Masaki Yamaguchi, Yasufumi Masaki, Internal Medicine, 58:2555-2560, Sep. 2019
  • Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?, Shino Fujimoto, Tomoyuki Sakai, Hiroshi Kawabata, Nozomu Kurose, Sohsuke Yamada, Kazue Takai, Sadao Aoki, Junya Kuroda, Makoto Ide, Keigo Setoguchi, Norifumi Tsukamoto, Haruka Iwao-Kawanami, Takafumi Kawanami, Shuichi Mizuta, Toshihiro Fukushima, Yasufumi Masaki, American Journal of Hematology, 94:975-983, Sep. 2019
  • Allogeneic haematopoietic stem cell transplantation for primary mediastinal large B‐cell lymphoma patients relapsing after high dose chemotherapy with autologous stem cell transplantation: data from the Japan Society for Haematopoietic Cell Transplantation registry, (Eisei Kondo), Risa Shimizu-Koresawa, Dai Chihara, Shuichi Mizuta, Koji Izutsu, Kazuhiro Ikegame, Naoyuki Uchida, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, Ritsuro Suzuki, for the Adult Lymphoma Working Group of the JSHCT, British Journal of Haematology, 186:e219-e223, Sep. 2019
  • Allogeneic stem cell transplantation for acute lymphoblastic leukemia in adolescents and young adults, (Mayumi Hangai), Kevin Y Urayama, Junji Tanaka, koji Kato, Satoshi Nishiwaki, Katsuyoshi Koh, Maiko Noguchi, Keisuke Kato, Nao Yoshida, Maho Sato, Hiroaki Goto, Yuki Yuza, Yoshiko Hashii, Yoshiko Atsuta, Shuichi Mizuta, Motohiro Kato, Biology of Blood and Marrow Transplantation, 25:1597-1602, Aug. 2019
  • Risk factors and timing of autologous stem cell tarnsplantation for patients with peripheral T-cell lymphoma, (Satoshi Yamasaki), Dai Chihara, Sung-Won Kim, Takahito Kawata, Shuichi Mizuta, Hiroatsu Ago, Takaaki Chou, Takahisa Yamane, Hitoji Uchiyama, Tatsuo Oyake, Katsuhiro Miura, Bungo Saito, Hirofumi Taji, Hirohisa Nakamae, Toshihiro Miyamoto, Takahiro Fukuda, Junya Kanda, Yoshiko Atsuta, Ritsuro Suzuki, International Journal of Hematology, 109:175-186, Feb. 2019
  • Plasma concentration of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study, Shuichi.Mizuta, Masashi.Sawa, Hisashi.Tsurumi, Kana.Matsumoto, Kotaro.Miyao, Takeshi.Hara, Takeshi.Takahashi,Reona.Sakemura, Hiroshi.Kojima, Akio.Kohno, Mari S.Oba, Satoshi.Morita, junichi.Sakamoto, Nobushiko.Emi, International Journal of Clinical Oncology, 23:980-988, Oct. 2018
  • Additional Cytogenetic Abnormalities with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia on Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitor Era., (Yu.Akahoshi), Shuichi.Mizuta, Hiroaki.Shimizu, Naoyuki.Uchida, Takahiro.Fukuda, Heiwa.Kanamori, Makoto.Ninizuka, Yukiyasu.Ozawa, Kazuteru.Ohashi,Shuichi.Ohta, Tetsuya.Eto, Junji.Tanaka, Yoshiko.Atsuta, Shinichi.Kato, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24:2009-2016, Oct. 2018
  • Final analysis of the JALSG Ph＋ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for ph＋ALL, (Yoshihiro.Hatta), Shuichi.Mizuta, Keitaro.Matsuo, Shigeki.Ohtake, Masako.Iwanaga, Isamu.Sugiura, Noriko.Doki, Heiwa.Kanamori, Yasunori.Ueda,Chikamasa.Yoshida, Nobuaki.Dobashi, Tomoya.Maeda, Toshiaki.Yujiri, Fumihiko.Monma, Yoshikazu.Ito, Fumihiko.Hayakawa, Jin.Takeuchi, Hitoshi.Kiyoi, Yasushi.Miyazaki, Tomoki.Naoe, Annals of Hematology, 97:1535-1545, Sep. 2018
  • Additional Cytogenetic Abnormalities with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia on Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitor Era., Akahoshi Yu;Mizuta Shuichi;Shimizu Hiroaki;Uchida Naoyuki;Fukuda Takahiro;Kanamori Heiwa;Onizuka Makoto;Ozawa Yukiyasu;Ohashi Kazuteru;Ohta Shuichi;Eto Tetsuya;Tanaka Junji;Atsuta Yoshiko;Kako Shinichi;, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2018
  • Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment., Okada Masaya;Imagawa Jun;Tanaka Hideo;Nakamae Hirohisa;Hino Masayuki;Murai Kazunori;Ishida Yoji;Kumagai Takashi;Sato Seiichi;Ohashi Kazuteru;Sakamaki Hisashi;Wakita Hisashi;Uoshima Nobuhiko;Nakagawa Yasunori;Minami Yosuke;Ogasawara Masahiro;Takeoka Tomoharu;Akasaka Hiroshi;Utsumi Takahiko;Uike Naokuni;Sato Tsutomu;Ando Sachiko;Usuki Kensuke;Mizuta Syuichi;Hashino Satoshi;Nomura Tetsuhiko;Shikami Masato;Fukutani Hisashi;Ohe Yokiko;Kosugi Hiroshi;Shibayama Hirohiko;Maeda Yasuhiro;Fukushima Toshihiro;Yamazaki Hirohito;Tsubaki Kazuo;Kukita Toshimasa;Adachi Yoko;Nataduka Toshiki;Sakoda Hiroto;Yokoyama Hisayuki;Okamoto Takahiro;Shirasugi Yukari;Onishi Yasushi;Nohgawa Masaharu;Yoshihara Satoshi;Morita Satoshi;Sakamoto Junichi;Kimura Shinya;, Clinical lymphoma, myeloma & leukemia, 18, 2018
  • Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults., Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, Hidaka M, Kobayashi N, Iwato K, Sakura T, Onizuka M, Ozawa Y, Eto T, Kurokawa M, Kahata K, Uchida N, Atsuta Y, Mizuta S, Kako S, Japan Society for Hematopoietic Cell Transplantation., 93:47-57, Oct. 2017
  • Comparison of Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Allogeneic Transplant Recipients 50 Years or Older., Kawamura K, Kako S, Mizuta S, Ishiyama K, Aoki J, Yano S, Fukuda T, Uchida N, Ozawa Y, Eto T, Iwato K, Kanamori H, Kahata K, Kondo T, Sawa M, Ichinohe T, Atsuta Y, Kanda Y, 23:2079-2087, Sep. 2017
  • An international investigation into O red blood cell unit administration in hospitals: the GRoup O Utilization Patterns (GROUP) study., Zeller MP, Barty R, Aandahl A, Apelseth TO, Callum J, Dunbar NM, Elahie A, Garritsen H, Hancock H, Kutner JM, Manukian B, Mizuta S, Okuda M, Pagano MB, Pogłód R, Rushford K, Selleng K, Sørensen CH, Sprogøe U, Staves J, Weiland T, Wendel S, Wood EM, van de Watering L, van Wordragen-Vlaswinkel M, Ziman A, Jan Zwaginga J, Murphy MF, Heddle NM, Yazer MH, Biomedical Excellence for Safer Transfusion (BEST) Collaborative., 57:2329-2337, Aug. 2017
  • GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia., Terakura S, Kuwatsuka Y, Yamasaki S, Wake A, Kanda J, Inamoto Y, Mizuta S, Yamaguchi T, Uchida N, Kouzai Y, Aotsuka N, Ogawa H, Kanamori H, Nishiwaki K, Miyakoshi S, Onizuka M, Amano I, Fukuda T, Ichinohe T, Atsuta Y, Murata M, Teshima T, 52:1261-1267, Jun. 2017
  • Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults., Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, Kawakita T, Mori T, Hoshino T, Onizuka M, Ozawa Y, Yoshida S, Ueda Y, Mizuno I, Atsuta Y, Mizuta S, Japan Society for Haematopoietic Cell Transplantation., 178:106-111, Apr. 2017
  • Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation., Shigematsu A, Kako S, Mitsuhashi K, Iwato K, Uchida N, Kanda Y, Fukuda T, Sawa M, Senoo Y, Ogawa H, Miyamura K, Takada S, Nagamura-Inoue T, Morishima Y, Ichinohe T, Atsuta Y, Mizuta S, Tanaka J, 105:805-811, Feb. 2017
  • Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia., Fujisawa S, Mizuta S, Akiyama H, Ueda Y, Aoyama Y, Hatta Y, Kakihana K, Dobashi N, Sugiura I, Onishi Y, Maeda T, Imai K, Ohtake S, Miyazaki Y, Ohnishi K, Matsuo K, Naoe T, 92:367-374, Jan. 2017
  • High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study., Arai Y, Kondo T, Shigematsu A, Tanaka J, Takahashi S, Kobayashi T, Uchida N, Onishi Y, Ishikawa J, Kanamori H, Sawa M, Yokota A, Kouzai Y, Takanashi M, Ichinohe T, Atsuta Y, Mizuta S, 51:1636-1639, Dec. 2016
  • Comparison of Cyclophosphamide Combined with TBI, Oral Busulfan, or Intravenous Busulfan for Allogeneic Transplantation in Adult Patients with ALL., Mitsuhashi K, Kako S, Shigematsu A, Atsuta Y, Doki N, Fukuda T, Kanamori H, Onizuka M, Takahashi S, Ozawa Y, Kurokawa M, Inoue Y, Nagamura-Inoue T, Morishima Y, Mizuta S, Tanaka J, Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation, 22:2194-2200, Sep. 2016
  • Transcriptional activation of platelet-derived growth factor receptor α and GS homeobox 2 resulting from E26 transformation-specific variant 6 translocation in a case of acute myeloid leukemia with t(4;12)(q12;p13)., Abe A, Mizuta S, Okamoto A, Yamamoto Y, Kameyama T, Mayeda A, Emi N, 38:e15-e18, Apr. 2016
  • TP53 mutations in older adults with acute myeloid leukemia., Yanada M, Yamamoto Y, Iba S, Okamoto A, Inaguma Y, Tokuda M, Morishima S, Kanie T, Mizuta S, Akatsuka Y, Okamoto M, Emi N, 103:435-435, Jan. 2016
  • ETV6-LPXN fusion transcript generated by t(11;12)(q12.1;p13) in a patient with relapsing acute myeloid leukemia with NUP98-HOXA9., Abe A, Yamamoto Y, Iba S, Kanie T, Okamoto A, Tokuda M, Inaguma Y, Yanada M, Morishima S, Mizuta S, Akatsuka Y, Okamoto M, Kameyama T, Mayeda A, Emi N, 55:242-250, Nov. 2015
  • Influence of melphalan plus fludarabine-conditioning regimen in elderly patients aged ⩾55 years with hematological malignancies., Miyao K, Sawa M, Kuwatsuka Y, Ozawa Y, Kato T, Kohno A, Sao H, Nishida T, Iida H, Naito K, Tsurumi H, Taji H, Mizuta S, Kusumoto S, Nakase K, Morishita Y, Kawashima N, Miyamura K, Murata M, 51:157-160, Oct. 2015
  • NUP214-RAC1 and RAC1-COL12A1 Fusion in Complex Variant Translocations Involving Chromosomes 6, 7 and 9 in an Acute Myeloid Leukemia Case with DEK-NUP214., Abe A, Yamamoto Y, Iba S, Okamoto A, Tokuda M, Inaguma Y, Yanada M, Morishima S, Kanie T, Tsuzuki M, Akatsuka Y, Mizuta S, Okamoto M, Kameyama T, Mayeda A, Emi N, 146:279-284, Oct. 2015
  • Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the adult ALL WG of the JSHCT., Nishiwaki S, Imai K, Mizuta S, Kanamori H, Ohashi K, Fukuda T, Onishi Y, Takahashi S, Uchida N, Eto T, Nakamae H, Yujiri T, Mori S, Nagamura-Inoue T, Suzuki R, Atsuta Y, Tanaka J, 51:43-50, Sep. 2015
  • Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma., Okamoto A, Yanada M, Miura H, Inaguma Y, Tokuda M, Morishima S, Kanie T, Yamamoto Y, Mizuta S, Akatsuka Y, Yoshikawa T, Mizoguchi Y, Nakamura S, Okamoto M, Emi N, 106:1581-1581, Sep. 2015
  • The fate of patients with acute myeloid leukemia not undergoing induction chemotherapy., Yanada M, Okamoto A, Inaguma Y, Tokuda M, Morishima S, Kanie T, Yamamoto Y, Mizuta S, Akatsuka Y, Okamoto M, Emi N, 102:35-40, Jul. 2015
  • The prognostic significance of EBV DNA load and EBER status in diagnostic specimens from diffuse large B-cell lymphoma patients., Okamoto A, Yanada M, Inaguma Y, Tokuda M, Morishima S, Kanie T, Yamamoto Y, Mizuta S, Akatsuka Y, Yoshikawa T, Mizoguchi Y, Nakamura S, Okamoto M, Emi N, 35:87-93, Jul. 2015
  • Evaluation of the potassium adsorption capacity of a potassium adsorption filter during rapid blood transfusion., Matsuura H, Akatsuka Y, Muramatsu C, Isogai S, Sugiura Y, Arakawa S, Murayama M, Kurahashi M, Takasuga H, Oshige T, Yuba T, Mizuta S, Emi N, 108:428-431, May 2015
  • A varicella outbreak in B-cell lymphoma patients receiving rituximab-containing chemotherapy., Okamoto A, Abe A, Okamoto M, Kobayashi T, Inaguma Y, Tokuda M, Yanada M, Morishima S, Kanie T, Yamamoto Y, Tsuzuki M, Mizuta S, Akatsuka Y, Yatsuya H, Yoshikawa T, Emi N, 20:774-777, Dec. 2014
  • Analysis of outcomes following autologous stem-cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia during the first complete remission., Kato H, Kawase T, Kako S, Mizuta S, Kurokawa M, Mori T, Ohashi K, Iwato K, Miyamura K, Hidaka M, Sakamaki H, Suzuki R, Morishima Y, Tanaka J, 99:e228-e230, Jul. 2014
  • High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed/refractory diffuse large B cell lymphoma: a nationwide retrospective study., Chihara D, Izutsu K, Kondo E, Sakai R, Mizuta S, Yokoyama K, Kaneko H, Kato K, Hasegawa Y, Chou T, Sugahara H, Henzan H, Sakamaki H, Suzuki R, Suzumiya J, 20:684-689, May 2014
  • Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL-positive acute lymphoblastic leukemia., Mizuta S, Matsuo K, Nishiwaki S, Imai K, Kanamori H, Ohashi K, Fukuda T, Onishi Y, Miyamura K, Takahashi S, Onizuka M, Atsuta Y, Suzuki R, Morishima Y, Kato K, Sakamaki H, Tanaka J, 123:2325-2332, Apr. 2014
  • CCAR1/CoCoA pair-mediated recruitment of the Mediator defines a novel pathway for GATA1 function., Mizuta S, Minami T, Fujita H, Kaminaga C, Matsui K, Ishino R, Fujita A, Oda K, Kawai A, Hasegawa N, Urahama N, Roeder RG, Ito M, 19:28-51, Jan. 2014
  • Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation., Kanamori H, Mizuta S, Kako S, Kato H, Nishiwaki S, Imai K, Shigematsu A, Nakamae H, Tanaka M, Ikegame K, Yujiri T, Fukuda T, Minagawa K, Eto T, Nagamura-Inoue T, Morishima Y, Suzuki R, Sakamaki H, Tanaka J, 48:1513-1518, Nov. 2013
  • Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experience., Okamoto A, Yanada M, Inaguma Y, Tokuda M, Morishima S, Kanie T, Yamamoto Y, Tsuzuki M, Akatsuka Y, Mizuta S, Okamoto M, Emi N, 18:74-80, Mar. 2013
  • Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy., Okamoto A, Abe A, Okamoto M, Kobayashi T, Terazawa T, Inaguma Y, Tokuda M, Yanada M, Morishima S, Kanie T, Yamamoto Y, Tsuzuki M, Akatsuka Y, Mizuta S, Yoshikawa T, Emi N, 96:516-520, Oct. 2012
  • Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR-ABL-positive ALL., Mizuta S, Matsuo K, Maeda T, Yujiri T, Hatta Y, Kimura Y, Ueda Y, Kanamori H, Usui N, Akiyama H, Takada S, Yokota A, Takatsuka Y, Tamaki S, Imai K, Moriuchi Y, Miyazaki Y, Ohtake S, Ohnishi K, Naoe T, 2:e72, May 2012
  • Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia., Mizuta S, Matsuo K, Yagasaki F, Yujiri T, Hatta Y, Kimura Y, Ueda Y, Kanamori H, Usui N, Akiyama H, Miyazaki Y, Ohtake S, Atsuta Y, Sakamaki H, Kawa K, Morishima Y, Ohnishi K, Naoe T, Ohno R, 25:41-47, Jan. 2011
  • [Alteration in antibody-mediated immunity in patients with rituximab-combined chemotherapy and incidence of herpes zoster]., Ito K, Okamoto M, Maruyama F, Handa K, Yamamoto Y, Watanabe M, Tsuzuki M, Mizuta S, Kumazawa S, Ohta H, Nakano I, Emi N, 37:99-102, Jan. 2010
  • Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinib., Tsuzuki M, Inaguma Y, Handa K, Hasegawa A, Yamamoto Y, Watanabe M, Mizuta S, Maruyama F, Okamoto M, Emi N, 48:1433-1435, 2009
  • Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission: a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group., Kohno A, Morishita Y, Iida H, Yanada M, Uchida T, Hamaguchi M, Sawa M, Sugiura I, Yamamoto K, Mizuta S, Sao H, Naoe T, Miyamura K, Nagoya Blood and Marrow Transplantation Group, 87:210-216, Mar. 2008
  • Chronic myeloid leukemia following chemotherapy with 5'-deoxy-5-fluorouridine for gastric cancer., Tsuzuki M, Handa K, Yamamoto K, Hasegawa A, Yamamoto Y, Watanabe M, Mizuta S, Maruyama F, Okamoto M, Emi N, Ezaki K, 47:1739-1741, 2008
  • Long-term follow-up of 14 patients with philadelphia chromosome-positive acute lymphoblastic leukemia following autologous bone marrow transplantation in first complete remission., Mizuta S, Kohno A, Morishita Y, Atsuta Y, Sao H, Miyamura K, Sakamaki H, Ueda R, Morishima Y, 85:140-145, Feb. 2007
  • Detection of AML1/MTG8 fusion gene of spinal granulocytic sarcoma in a nonleukemic patient using the real-time polymerase chain reaction., Nakashima S, Suzuki K, Watanabe K, Urata S, Mizuta S, Matsuyama Y, Ishiguro N, 10:414-417, Jul. 2005
  • Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation., Yanada M, Yamamoto K, Emi N, Naoe T, Suzuki R, Taji H, Iida H, Shimokawa T, Kohno A, Mizuta S, Maruyama F, Wakita A, Kitaori K, Yano K, Hamaguchi M, Hamajima N, Morishima Y, Kodera Y, Sao H, Morishita Y, 32:801-807, Oct. 2003
  • Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study., Takeuchi J, Kyo T, Naito K, Sao H, Takahashi M, Miyawaki S, Kuriyama K, Ohtake S, Yagasaki F, Murakami H, Asou N, Ino T, Okamoto T, Usui N, Nishimura M, Shinagawa K, Fukushima T, Taguchi H, Morii T, Mizuta S, Akiyama H, Nakamura Y, Ohshima T, Ohno R, 16:1259-1266, Jul. 2002
  • [Intestinal permeability in Crohn's disease and effects of elemental dietary therapy]., Iwata M, Nakano H, Matsuura Y, Nagasaka M, Misawa M, Mizuta S, Ito I, Saito T, Ito T, Hokama M, Kamiya M, Hobara R, Watanabe M, Takahama K, 98:636-643, Jun. 2001
  • Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation. Nagoya BMT Group., Mizuta S, Ito Y, Kohno A, Kiyoi H, Miyamura K, Tanimoto M, Takamatsu J, Naoe T, Morishima Y, Ueda R, Saito H, 24:777-784, Oct. 1999
  • [Autologous BMT for B-lineage adult ALL patients using ex vivo purging with monoclonal antibodies]., Mizuta S, Kawano A, 38:422-425, May 1997
  • Establishment and characterization of a novel cell line, TK-6, derived from T cell blast crisis of chronic myelogenous leukemia, with the secretion of parathyroid hormone-related protein., Watanabe T, Kataoka T, Mizuta S, Kobayashi M, Uchida T, Imai K, Wada H, Kinoshita T, Murate T, Mizutani S, 9:1926-1934, Nov. 1995
  • [Simultaneous analysis of c-myc protein expression and cell cycle with monoclonal antibody and flow cytometry]., Mizuta S, Takamoto S, Naoe T, 50:2465-2470, Oct. 1992
  • [Weekly CHOP chemotherapy in the treatment of intermediate-grade non-Hodgkin's lymphomas--cooperative group study by seven institutes]., Kobayashi M, Sao H, Mizuta S, Kamiya O, Ohara K, Nagata K, Takeyama H, Watanabe E, Yamada H, Mizuno H, 31:1656-1663, Oct. 1990
  • Minimal residual disease (MRD) posigivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of philadelphia chromoaome-positive adute lymphoblastic leukemia, (Yu Akahoshi), Yasuyuki Arai, Satoshi Nishiwaki, Shuichi Mizuta, Atsushi Marumo, Naoyuki Uchida, Yoshinobu Kanda, Hitoshi Sakai, Satoru Takada, Takahiro Fukuda, Shin Fujisawa, Takashi Ashida, Junji Tanaka, Yoshiko Atsuta, Shinichi Kako, International Journal of Hematology, 113:832-839, 2021
  • Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph+ ALL during both CR1 and CR2, (Satoshi Nishiwaki), Yu Akahoshi, Shuichi Mizuta, Akihito Shinohara, Shigeki Hirabayashi, Yuma Noguchi, Takahiro Fukuda, Naoyuki Uchida, Masatsugu Tanaka, Makoto Onizuka, Yukiyasu Ozawa, Shuichi Ota, Souichi Shiratori, Yasushi Onishi, Yoshinobu Kanda, Masashi Sawa, Junji Tanaka, Yoshihiko Atsuta, and Shinichi Kako, for the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation, blood advances, 5:584-592, 2021
  • Comprehensive analysis of protein-expression changes specific to immunoglobulin G4-related disease, Takafumi Kawanami, Haruka Kawanami-Iwao, Takanobu Takata, Yasuhito Ishigaki, Naohisa Tomosugi, Tsutomu Takegami, Hiroto Yanagisawa, Shino Fujimoto, Tomoyuki Sakai, Yoshimasa Fujita, Kazunori Yamada, Shuichi Mizuta, Hiroshi Kawabata, Toshihiro Fukushima, Yuko Hirose, Yasufumi Masaki, Clinica Chimica Acta, 523:45-57, 2021
  • Faggot cells in acute myeloid leukemia with t(7;11)(p15;p15) and NUP98-HOXA9 fusion, Hiroto Yanagisawa, Shuichi Mizuta, Hiroshi Kawabata, Shino Fujimoto, Tomoyuki Sakai, Haruka Iwao-Kawanami, Takafumi Kawanami, Kazunori Yamada, Toshihiro Fukushima, Katsunori Kyoda, Yasufumi Masaki, Annals of Hematology, 100:2121-2123, Aug. 2021
  • Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy, Shinichi Kako, Fumihiko Hayakawa, Kiyotoshi Imai, Junji Tanaka, Shuichi Mizuta, Satoshi Nishiwaki, Heiwa Kanamori, Junichi Mukae, Yukiyasu Ozawa, Tadakazu Kondo, Takahiro Fukuda, Tatsuo Ichinohe, Shuichi Ota, Yoshinori Tanaka, Tohru Murayama, Shingo Kurahashi, Toru Sakura, Noriko Usui, Shigeki Ohtake, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki & Yoshiko Atsuta, International Journal of Hematology, 114:608-619, 2021
  • RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia, (Tatsuya Masuda), Shintaro Maeda, Sae Shimada, Naoya Sakuramoto, Ken Morita, Asami Koyama, Kensho Suzuki, Yoshihide Mitsuda, Hidemasa Matsuo, Hirohito Kubota, Itaru Kato, Kuniaki Tanaka, Junko Takita, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Souichi Adachi, Hideo Hirai, Shuichi Mizuta, Kazuhito Naka, Yoichi Imai, Shinya Kimura, Hiroshi Sugiyama, Yasuhiko Kamikubo, Cancer Science, 113:529-539, Feb. 2022
  • Propensity score matching/reweighting analysis comparing autologous and allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia, Shuichi Mizuta, Tomotaka Ugai, Harumi Kato, Noriko Doki, Shuichi Ota, Toshiro Kawakita, Yuta Katayama, Mineo Kurokawa, Hirohisa Nakamae, Shingo Yano, Yuichiro Nawa, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Shinichi Kako, International Journal of Hematology, 116:393-400, 2022
  • Prognostic impacts of serum levels of C-reactive protein, albumin, and total cholesterol in patients with myelodysplastic syndromes, Hiroto Yanagisawa, Hiroshi Kawabata, Yusuke Ueda, Kotaro Arita, Haruka Iwao-Kawanami, Tomoyuki Sakai, Takafumi Kawanami, Kazunori Yamada, Shuichi Mizuta, Toshihiro Fukushima, Yasufumi Masaki, International Journal of Hematology, 116:81-88, 2022
  • The first reported case of allogenic hematopoietic stem cell transplantation for CML blast phase (monocytic lineage) in the tyrosine kinase inhibitor era, (Shinya Yamada), Kotaro Arita, Yukio Kondo, Shuichi Mizuta, Hirokazu Okumura, Case Reports in Oncology, 15:535-540, 2022
  • TAFRO syndrome: A disease requiring immediate medical attention, Yasufumi Masaki, Yusuke Ueda, Hiroto Yanagisawa, Kotaro Arita, Tomoyuki Sakai, Kazunori Yamada, Shuichi Mizuta, Toshihiro Fukushima, Kazue Takai, Sadao Aoki, and Hiroshi Kawabawa, Internal Medicien, 62:27-32, Jan. 2023
  • Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph+ ALL: A retrospective nationwide study, (Shigeki Hirabayashi), Tadakazu Kondo, Satoshi Nishiwaki, Shuichi Mizuta, Noriko Doki, Takahiro Fukuda, Naoyuki Uchida, Yukiyasu Ozawa, Yoshinobu Kanda, Ryota Imanaka, Satoshi Takahashi, Jun Ishikawa, Shingo Yano, Hirohisa Nakamae, Tetsuya Eto, Takafumi Kimura, Junji Tanaka, Tatsuo Ichinohe, Yoshiko Atsuta, Shinichi Kako, 98:1606-1618, Oct. 2023
  • Primary Effusion Lymphoma-like ATL Developing during Hemodialysis, (Miharu Masak)i, Yuki Okushi, Atsushi Saito, Akihiro Fukuda, Sohsuke Yamada, Shuichi Mizuta, Yasufumi Masaki, Internal Medicine, 62:1807-1811, Jun. 2023
  • Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells, Terutsugu Koya, Kenichi Yoshida, Misa Togi, Yo Niida, Sumihito Togi, Hiroki Ura, Shuichi Mizuta, Tomohisa Kato Jr, Sohsuke Yamada, Takeo Shibata, Yi-Chang Liu, Shyng-Shiou Yuan, Deng-Chyang Wu, Hirohito Kobayashi, Taiju Utsugisawa, Hitoshi Kanno, Shigetaka Shimodaira, Cancers, 15:3627, Jul. 2023